$CLOW
Cloudweb, Inc.

2023 Q2 Form 10-Q Financial Statement

#000164033423000769 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.50K $8.900K
YoY Change -35.23% -99.99%
% of Gross Profit
Research & Development $18.50K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.55K $12.50K $27.40K
YoY Change -219.88% -35.23% -99.97%
Operating Profit
YoY Change
Interest Expense $9.043K $8.943K -$9.140K
YoY Change -6.14% -8.07% -94.49%
% of Operating Profit
Other Income/Expense, Net -$9.043K -$8.943K
YoY Change -6.14% -8.07%
Pretax Income -$21.44K -$36.54K
YoY Change -26.15% -99.97%
Income Tax
% Of Pretax Income
Net Earnings -$20.59K -$21.44K -$36.54K
YoY Change 7.62% -26.13% -99.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 27.82M shares 27.82M shares 27.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.22K $59.66K
YoY Change -3.98% 6.33%
Accrued Expenses $95.16K $91.59K
YoY Change -38.09% -36.65%
Deferred Revenue
YoY Change
Short-Term Debt $113.7K $96.76K
YoY Change
Long-Term Debt Due $155.6K $155.6K
YoY Change -1.22% -0.84%
Total Short-Term Liabilities $535.2K $514.6K $493.1K
YoY Change 22.1% 22.03% 25.6%
LONG-TERM LIABILITIES
Long-Term Debt $67.33K $67.33K
YoY Change 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $67.33K $67.33K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $535.2K $514.6K $493.1K
Total Long-Term Liabilities $67.33K $67.33K
Total Liabilities $602.5K $581.9K $560.4K
YoY Change 19.16% 19.0% 21.85%
SHAREHOLDERS EQUITY
Retained Earnings -$233.4M -$233.3M -$233.3M
YoY Change 0.04% 0.04%
Common Stock $237.9M $237.9M $237.9M
YoY Change 0.0% 128.24% 85.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$602.5K -$581.9K -$560.4K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$20.59K -$21.44K -$36.54K
YoY Change 7.62% -26.13% -99.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$16.94K -$24.35K
YoY Change -5.37% 275.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.94K 24.35K
YoY Change -5.37% 275.77%
NET CHANGE
Cash From Operating Activities -$16.94K -24.35K
Cash From Investing Activities
Cash From Financing Activities $16.94K 24.35K
Net Change In Cash $0.00 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$16.94K -$24.35K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-560442 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q1 us-gaap Other Notes Payable
OtherNotesPayable
2160 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
2160 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
113699 usd
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0978297
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
800 W El Camino Real Suite 180
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94040
CY2023Q1 dei City Area Code
CityAreaCode
650
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
963-7749
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27819385 shares
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001619227
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27819385 shares
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-199193
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Cloudweb, Inc.
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
96760 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
237937821 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-5091518 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233310529 usd
CY2022Q4 clow Accumulated Deficit From Discontinued Operations
AccumulatedDeficitFromDiscontinuedOperations
-96216 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
9728 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9728 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-29028 usd
CY2022Q1 clow Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
-0.00
CY2022Q1 clow Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
20825003 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-560442 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21443 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-581885 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
21443 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
29028 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
600 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4440 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1397 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
8944 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
9131 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16939 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17900 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16939 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17900 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16939 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17900 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
104250000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55327097 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
57826667 shares
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
113699 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
96760 usd
CY2022 clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
CY2021 clow Total Promissory Notes Payable
TotalPromissoryNotesPayable
69486 usd
CY2022 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
CY2021 clow Less Current Portion Of Promissory Note Payable
LessCurrentPortionOfPromissoryNotePayable
-2160 usd
CY2022 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2021 clow Longterm Promissory Notes Payable
LongtermPromissoryNotesPayable
67326 usd
CY2023Q1 clow Accrued Interest On Promissory Notes
AccruedInterestOnPromissoryNotes
94838 usd
CY2022Q4 clow Accrued Interest On Promissory Notes
AccruedInterestOnPromissoryNotes
89464 usd
CY2022Q4 clow Less Debt Discount
LessDebtDiscount
0 usd
CY2021Q4 clow Less Debt Discount
LessDebtDiscount
-1184 usd
CY2022Q4 clow Total Current Portion Of Convertible Note Payable
TotalCurrentPortionOfConvertibleNotePayable
153482 usd
CY2021Q4 clow Total Current Portion Of Convertible Note Payable
TotalCurrentPortionOfConvertibleNotePayable
154798 usd
CY2022Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-153482 usd
CY2021Q4 clow Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-154798 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q1 clow Convertible Note1
ConvertibleNote1
3574 usd
CY2022 clow Net Note Discount
NetNoteDiscount
153482 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
153482 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
95164 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
91594 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27819385 shares

Files In Submission

Name View Source Status
0001640334-23-000769-index-headers.html Edgar Link pending
0001640334-23-000769-index.html Edgar Link pending
0001640334-23-000769.txt Edgar Link pending
0001640334-23-000769-xbrl.zip Edgar Link pending
clow-20230331.xsd Edgar Link pending
clow_10q.htm Edgar Link pending
clow_ex311.htm Edgar Link pending
clow_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
clow_10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clow-20230331_lab.xml Edgar Link unprocessable
clow-20230331_def.xml Edgar Link unprocessable
clow-20230331_cal.xml Edgar Link unprocessable
clow-20230331_pre.xml Edgar Link unprocessable